Q3 2025 Lantheus Holdings Inc Earnings Call Transcript
Key Points
- Lantheus Holdings Inc (LNTH) reported a 1.4% increase in consolidated net revenue for the third quarter, reaching $384 million.
- The company is preparing for the potential approval of a new F-18 PSMA PET formulation in 2026, which could enhance production efficiency and patient access.
- Definity, an ultrasound enhancing agent, grew more than 6% year over year, demonstrating consistent performance and market leadership.
- Lantheus Holdings Inc (LNTH) is advancing its position in the Alzheimer's disease imaging market with significant growth potential driven by expanded PET imaging guidelines.
- The company completed strategic acquisitions, including Life Molecular Imaging, which are expected to diversify revenue streams and strengthen capabilities in radiopharmaceuticals.
- Sales of Polarify, a key product, decreased by approximately 7% year over year, reflecting challenges in maintaining market share.
- Gross profit margin decreased by 471 basis points, attributed to unfavorable pricing impacts and inclusion of acquisitions with lower margin profiles.
- Operating expenses increased by 775 basis points compared to the prior year, driven by acquisitions and additional R&D investments.
- Net income for the third quarter decreased by 30.9% on an adjusted basis, indicating financial pressure despite revenue growth.
- The company faces potential price compression in the fourth quarter due to 340B or best price resets, impacting future financial performance.
Good morning. Welcome to Lathea's 3rd quarter 2025 conference call. All lines have been placed on mute. This call is being recorded, and a replay will be available in the investors section of the company's website approximately 2 hours after the completion of the call and will be archived for at least 30 days.
I'll now turn the call over to Mark Karney, Vice President of Investor relations. Mark.
Thank you. Good morning. With me today are Brian Marcusson, our CEO, and Bob Marshall, our CFO. We will begin with prepared remarks and then take your questions.
This morning we issued a press release which was furnished to the SEC under Form 8k reporting our third quarter 2025 results. The release and today's slide presentation are available in the investors section of our website.
Any comments could include forward-looking statements. Actual results may differ materially from these statements due to a variety of risks and uncertainties which are detailed in our SEC
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
